1119282-87-9

Upstream product

• 766558-31-0 N-(2-hydroxyethyl)-4-methoxy-2,6,N-trimethylbenzenesulphonamide 
• 766558-32-1 [2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]acetic acid 1,1-dimethylethyl ester 
• 885280-38-6 (3-oxo-cyclohexyl)-carbamic acid tert-butyl ester 
• 55661-08-0 4-methoxy-2,6-dimethylbenzenesulfonyl chloride 
• 1119283-49-6 tert-butyl [3-(4-methylpiperazin-1-yl)cyclohexyl]carbamate 
• 874-63-5 3,5-dimethylmethoxybenzene 
• 766558-33-2 [2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]acetic acid 

Relevant academic research and scientific papers

ACID ADDITION SALTS OF THE 2-[2-[[(4-METHOXY-2,6-DIMETHYLPHENYL)SULFONYL]-(METHYL)AMINO]ETHOXY]-N-METHYL-N-[3-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL] ACETAMIDE AND THE USE THEREOF AS BRADYKININ B1 RECEPTORANTAGONISTS

The present invention relates to the new acid addition salts AB of the following free base of formula A or the enantiomer thereof with a physiologically acceptable acid B which is selected from among hydrochloric acid, fumaric acid and tartaric acid, as well as the polymorphs, hydrates and solvates thereof.

NEW COMPOUNDS

Novel compounds of which the following is exemplary: